BioNexus Gene Lab Corp Quarterly Current Ratio in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BioNexus Gene Lab Corp quarterly Current Ratio history and growth rate from Q3 2019 to Q3 2024.
  • BioNexus Gene Lab Corp Current Ratio for the quarter ending September 30, 2024 was 500 %, a 42% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 500 +148 +42% Sep 30, 2024
Q2 2024 502 +175 +53.8% Jun 30, 2024
Q1 2024 429 +75.1 +21.2% Mar 31, 2024
Q4 2023 402 +53.5 +15.3% Dec 31, 2023
Q3 2023 352 +3.81 +1.09% Sep 30, 2023
Q2 2023 326 +8.84 +2.79% Jun 30, 2023
Q1 2023 354 +58 +19.6% Mar 31, 2023
Q4 2022 349 +73.2 +26.6% Dec 31, 2022
Q3 2022 349 +90.6 +35.1% Sep 30, 2022
Q2 2022 317 +58.4 +22.6% Jun 30, 2022
Q1 2022 296 +33.4 +12.7% Mar 31, 2022
Q4 2021 275 -17.7 -6.03% Dec 31, 2021
Q3 2021 258 -1.47K -85.1% Sep 30, 2021
Q2 2021 259 -1.75K -87.1% Jun 30, 2021
Q1 2021 262 -1.78K -87.1% Mar 31, 2021
Q4 2020 293 -1.77K -85.8% Dec 31, 2020
Q3 2020 1.73K -420 -19.5% Sep 30, 2020
Q2 2020 2.01K Jun 30, 2020
Q1 2020 2.04K Mar 31, 2020
Q4 2019 2.07K Dec 31, 2019
Q3 2019 2.15K Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.